A study [62] conducted by researchers in the Cell Journal has discovered that antigen-specific CD8 + T cells, derived from tumour-draining lymph nodes (TDLNs), undergo expansion in both in vivo and in vitro experiments when subjected to PD-1/PD-L1 ICB treatment within the tumour tissue. The gene discussed is CD8A; the disease is neoplasm.